Bone marrow-derived mesenchymal stem cells attenuate myocardial ischemia–reperfusion injury via upregulation of splenic regulatory T cells

BACKGROUND: Myocardial ischemia–reperfusion injury (MIRI) is the main pathological manifestation of cardiovascular diseases such as myocardial infarction. The potential therapeutic effects of bone marrow-derived mesenchymal stem cells (BM-MSCs) and the participation of regulatory T cells (Tregs) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Pang, Ling-Xiao, Cai, Wen-Wei, Li, Qian, Li, Heng-Jie, Fei, Min, Yuan, Yong-Sheng, Sheng, Bin, Zhang, Ke, An, Rong-Cheng, Ou, Ying-Wei, Zeng, Wen-Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080373/
https://www.ncbi.nlm.nih.gov/pubmed/33906602
http://dx.doi.org/10.1186/s12872-021-02007-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080373/
https://www.ncbi.nlm.nih.gov/pubmed/33906602
http://dx.doi.org/10.1186/s12872-021-02007-4

Ejemplares similares